FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Int J Mol Sci / Tenogenic Properties of Mesenchymal Progenitor Cells Are Com...
International journal of molecular sciences2018; 19(9); doi: 10.3390/ijms19092549

Tenogenic Properties of Mesenchymal Progenitor Cells Are Compromised in an Inflammatory Environment.

Abstract: Transplantation of multipotent mesenchymal progenitor cells is a valuable option for treating tendon disease. Tenogenic differentiation leading to cell replacement and subsequent matrix modulation may contribute to the regenerative effects of these cells, but it is unclear whether this occurs in the inflammatory environment of acute tendon disease. Equine adipose-derived stromal cells (ASC) were cultured as monolayers or on decellularized tendon scaffolds in static or dynamic conditions, the latter represented by cyclic stretching. The impact of different inflammatory conditions, as represented by supplementation with interleukin-1β and/or tumor necrosis factor-α or by co-culture with allogeneic peripheral blood leukocytes, on ASC functional properties was investigated. High cytokine concentrations increased ASC proliferation and osteogenic differentiation, but decreased chondrogenic differentiation and ASC viability in scaffold culture, as well as tendon scaffold repopulation, and strongly influenced musculoskeletal gene expression. Effects regarding the latter differed between the monolayer and scaffold cultures. Leukocytes rather decreased ASC proliferation, but had similar effects on viability and musculoskeletal gene expression. This included decreased expression of the tenogenic transcription factor scleraxis by an inflammatory environment throughout culture conditions. The data demonstrate that ASC tenogenic properties are compromised in an inflammatory environment, with relevance to their possible mechanisms of action in acute tendon disease.
Get Full Text
Publication Date: 2018-08-28 PubMed ID: 30154348PubMed Central: PMC6163784DOI: 10.3390/ijms19092549Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research indicates that the potential for multipotent mesenchymal progenitor cells to regenerate tendon tissue may be compromised when exposed to inflammation, as is found in cases of acute tendon disease. This finding questions the efficacy of these cells in treating tendon disease in such conditions.

Study Overview

  • The primary aim of the study was to assess how the potential of multipotent mesenchymal progenitor cells (specifically, adipose-derived stromal cells or ASC) for tendon regeneration (tenogenesis) is impacted under conditions of inflammation.
  • The ASC were cultured in different environments – as monolayers or on decellularized tendon scaffolds, under either static conditions or conditions of cyclic stretching that mimic the dynamic environment within the body’s tissues.
  • The inflammatory conditions were represented either by supplements of interleukin-1β and/or tumor necrosis factor-α, or by co-culturing with allogeneic peripheral blood leukocytes (white blood cells of a different individual of the same species).

Findings

  • High concentrations of the inflammation-associated cytokines led to an increase in the proliferation and osteogenic (bone-tissue related) differentiation of the ASC, but decreased their chondrogenic (cartilage-tissue related) differentiation and viability in the scaffold culture.
  • Also, the repopulation of the tendon scaffold by ASC and the expression of specific musculoskeletal genes by the ASC was negatively affected by the high cytokine levels. The effects on gene expression varied between the monolayer and scaffold cultures.
  • Co-culture with leukocytes similarly led to decreased ASC proliferation and viability, and influenced musculoskeletal gene expression, including a decrease in the expression of the tenogenic transcription factor scleraxis.
  • Overall, these findings indicated that the tenogenic properties of the ASC were compromised in an inflammatory environment, suggesting that potential regenerative effects of these cells may be limited in cases of acute tendon disease where inflammation is present.

Relevance

  • This study sheds important light on the potential limitations of ASC transplantation for tendon disease treatment, as the regenerative effects of these cells may be compromised under the inflammatory conditions often present in acute instances of the disease.
  • It suggests that approaches for controlling inflammation may need to be considered in conjunction with cell transplantation therapies for the treatment of tendon disease.

Cite This Article

APA
Brandt L, Schubert S, Scheibe P, Brehm W, Franzen J, Gross C, Burk J. (2018). Tenogenic Properties of Mesenchymal Progenitor Cells Are Compromised in an Inflammatory Environment. Int J Mol Sci, 19(9). https://doi.org/10.3390/ijms19092549

Publication

International journal of molecular sciences
ISSN: 1422-0067
NlmUniqueID: 101092791
Country: Switzerland
Language: English
Volume: 19
Issue: 9

Researcher Affiliations

Brandt, Luisa
  • Saxon Incubator for Clinical Translation (SIKT), University of Leipzig, 04103 Leipzig, Germany. luisa.brandt@sikt.uni-leipzig.de.
Schubert, Susanna
  • Saxon Incubator for Clinical Translation (SIKT), University of Leipzig, 04103 Leipzig, Germany. susanna.schubert@sikt.uni-leipzig.de.
  • Institute of Veterinary Physiology, University of Leipzig, 04103 Leipzig, Germany. susanna.schubert@sikt.uni-leipzig.de.
Scheibe, Patrick
  • Saxon Incubator for Clinical Translation (SIKT), University of Leipzig, 04103 Leipzig, Germany. patrick.scheibe@sikt.uni-leipzig.de.
Brehm, Walter
  • Saxon Incubator for Clinical Translation (SIKT), University of Leipzig, 04103 Leipzig, Germany. brehm@vetmed.uni-leipzig.de.
  • Department for Horses, Veterinary Teaching Hospital, University of Leipzig, 04103 Leipzig, Germany. brehm@vetmed.uni-leipzig.de.
Franzen, Jan
  • Saxon Incubator for Clinical Translation (SIKT), University of Leipzig, 04103 Leipzig, Germany. jan.franzen96@gmx.de.
  • Institute of Veterinary Physiology, University of Leipzig, 04103 Leipzig, Germany. jan.franzen96@gmx.de.
Gross, Claudia
  • Saxon Incubator for Clinical Translation (SIKT), University of Leipzig, 04103 Leipzig, Germany. claudia_gross1@gmx.de.
Burk, Janina
  • Saxon Incubator for Clinical Translation (SIKT), University of Leipzig, 04103 Leipzig, Germany. burk@rz.uni-leipzig.de.
  • Institute of Veterinary Physiology, University of Leipzig, 04103 Leipzig, Germany. burk@rz.uni-leipzig.de.
  • Institute of Biotechnology, University of Natural Resources and Life Sciences (BOKU), 1190 Vienna, Austria. burk@rz.uni-leipzig.de.

MeSH Terms

  • Adipogenesis
  • Animals
  • Biomarkers
  • Cell Differentiation
  • Cell Survival
  • Cells, Cultured
  • Cellular Microenvironment
  • Chondrogenesis
  • Coculture Techniques
  • Cytokines / metabolism
  • Extracellular Matrix / metabolism
  • Horses
  • Humans
  • Inflammation / etiology
  • Inflammation / metabolism
  • Inflammation / pathology
  • Inflammation Mediators / metabolism
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • Tendons
  • Tissue Scaffolds

Grant Funding

  • BU3110/1-1 / Deutsche Forschungsgemeinschaft

Conflict of Interest Statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.

References

This article includes 56 references
  1. Anderson J.A., Little D., Toth A.P., Moorman C.T., Tucker B.S., Ciccotti M.G., Guilak F.. Stem cell therapies for knee cartilage repair: The current status of preclinical and clinical studies.. Am. J. Sports Med. 2014;42:2253–2261.
    doi: 10.1177/0363546513508744pmc: PMC4019709pubmed: 24220016google scholar: lookup
  2. Lui P.P.Y.. Stem cell technology for tendon regeneration: Current status, challenges, and future research directions.. Stem Cells Cloning 2015;8:163–174.
    doi: 10.2147/SCCAA.S60832pmc: PMC4685888pubmed: 26715856google scholar: lookup
  3. Liu L., Hindieh J., Leong D.J., Sun H.B.. Advances of stem cell based-therapeutic approaches for tendon repair.. J. Orthop. Translat. 2017;9:69–75.
    doi: 10.1016/j.jot.2017.03.007pmc: PMC5822968pubmed: 29662801google scholar: lookup
  4. Patruno M., Martinello T.. Treatments of the injured tendon in Veterinary Medicine: From scaffolds to adult stem cells.. Histol. Histopathol. 2014;29:417–422.
    pubmed: 24203578
  5. Smith R.K., Korda M., Blunn G.W., Goodship A.E.. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.. Equine Vet. J. 2003;35:99–102.
    doi: 10.2746/042516403775467388pubmed: 12553472google scholar: lookup
  6. Patterson-Kane J.C., Becker D.L., Rich T.. The pathogenesis of tendon microdamage in athletes: The horse as a natural model for basic cellular research.. J. Comp. Pathol. 2012;147:227–287.
    doi: 10.1016/j.jcpa.2012.05.010pubmed: 22789861google scholar: lookup
  7. Hillmann A., Ahrberg A.B., Brehm W., Heller S., Josten C., Paebst F., Burk J.. Comparative Characterization of Human and Equine Mesenchymal Stromal Cells: A Basis for Translational Studies in the Equine Model.. Cell Transplant. 2016;25:109–124.
    doi: 10.3727/096368915X687822pubmed: 25853993google scholar: lookup
  8. Godwin E.E., Young N.J., Dudhia J., Beamish I.C., Smith R.K.. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet. J. 2012;44:25–32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  9. Pacini S., Spinabella S., Trombi L., Fazzi R., Galimberti S., Dini F., Carlucci F., Petrini M.. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.. Tissue Eng. 2007;13:2949–2955.
    doi: 10.1089/ten.2007.0108pubmed: 17919069google scholar: lookup
  10. Smith R.K., Werling N.J., Dakin S.G., Alam R., Goodship A.E., Dudhia J.. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.. PLoS ONE 2013;8:e75697.
    doi: 10.1371/annotation/a30a4b87-8904-4510-b0a8-5b6ca6097f9apmc: PMC3783421pubmed: 24086616google scholar: lookup
  11. Shearn J.T., Kinneberg K.R., Dyment N.A., Galloway M.T., Kenter K., Wylie C., Butler D.L.. Tendon tissue engineering: Progress, challenges, and translation to the clinic.. J. Musculoskelet. Neuronal Interact. 2011;11:163–173.
    pmc: PMC3689273pubmed: 21625053
  12. Chong A.K., Chang J., Go J.C.. Mesenchymal stem cells and tendon healing.. Front Biosci. 2009;14:4598–4605.
    doi: 10.2741/3552pubmed: 19273374google scholar: lookup
  13. Andia I., Maffulli N.. Biological Therapies in Regenerative Sports Medicine.. Sports Med. 2017;47:807–828.
    doi: 10.1007/s40279-016-0620-zpubmed: 27677916google scholar: lookup
  14. Kavanagh D.P.J., Robinson J., Kalia N.. Mesenchymal stem cell priming: Fine-tuning adhesion and function.. Stem Cell Rev. 2014;10:587–599.
    doi: 10.1007/s12015-014-9510-7pubmed: 24752328google scholar: lookup
  15. Najar M., Krayem M., Merimi M., Burny A., Meuleman N., Bron D., Raicevic G., Lagneaux L.. Insights into inflammatory priming of mesenchymal stromal cells: Functional biological impacts.. Inflamm. Res. 2018;67:467–477.
    doi: 10.1007/s00011-018-1131-1pubmed: 29362849google scholar: lookup
  16. Dakin S.G., Dudhia J., Smith R.K.. Resolving an inflammatory concept: The importance of inflammation and resolution in tendinopathy.. Vet. Immunol. Immunopathol. 2014;158:121–127.
    doi: 10.1016/j.vetimm.2014.01.007pmc: PMC3991845pubmed: 24556326google scholar: lookup
  17. Docheva D., Müller S.A., Majewski M., Evans C.H.. Biologics for tendon repair.. Adv. Drug Deliv. Rev. 2015;84:222–239.
    doi: 10.1016/j.addr.2014.11.015pmc: PMC4519231pubmed: 25446135google scholar: lookup
  18. Berner D., Brehm W., Gerlach K., Gittel C., Offhaus J., Paebst F., Scharner D., Burk J.. Longitudinal Cell Tracking and Simultaneous Monitoring of Tissue Regeneration after Cell Treatment of Natural Tendon Disease by Low-Field Magnetic Resonance Imaging.. Stem Cells Int. 2016;2016:1207190.
    doi: 10.1155/2016/1207190pmc: PMC4736965pubmed: 26880932google scholar: lookup
  19. Burk J., Berner D., Brehm W., Hillmann A., Horstmeier C., Josten C., Paebst F., Rossi G., Schubert S., Ahrberg A.B.. Long-Term Cell Tracking following Local Injection of Mesenchymal Stromal Cells in the Equine Model of Induced Tendon Disease.. Cell Transplant. 2016;25:2199–2211.
    doi: 10.3727/096368916X692104pubmed: 27392888google scholar: lookup
  20. Geburek F., Mundle K., Conrad S., Hellige M., Walliser U., van Schie H.T., van W.R., Skutella T., Stadler P.M.. Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions-a pilot study.. Stem Cell Res. Ther. 2016;7:21.
    doi: 10.1186/s13287-016-0281-8pmc: PMC4736260pubmed: 26830812google scholar: lookup
  21. Dudhia J., Becerra P., Valdés M.A., Neves F., Hartman N.G., Smith R.K.. In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy.. J. Vis. Exp. 2015;106:e52748.
    doi: 10.3791/52748pmc: PMC4692789pubmed: 26709915google scholar: lookup
  22. Burk J., Plenge A., Brehm W., Heller S., Pfeiffer B., Kasper C.. Induction of Tenogenic Differentiation Mediated by Extracellular Tendon Matrix and Short-Term Cyclic Stretching.. Stem Cells Int. 2016;2016:7342379.
    doi: 10.1155/2016/7342379pmc: PMC5007347pubmed: 27630718google scholar: lookup
  23. Youngstrom D.W., Rajpar I., Kaplan D.L., Barrett J.G.. A bioreactor system for in vitro tendon differentiation and tendon tissue engineering.. J. Orthop. Res. 2015;33:911–918.
    doi: 10.1002/jor.22848pmc: PMC5098427pubmed: 25664422google scholar: lookup
  24. Youngstrom D.W., LaDow J.E., Barrett J.G.. Tenogenesis of bone marrow-, adipose-, and tendon-derived stem cells in a dynamic bioreactor.. Connect. Tissue Res. 2016;57:454–465.
    doi: 10.3109/03008207.2015.1117458pubmed: 27028488google scholar: lookup
  25. Martinello T., Bronzini I., Perazzi A., Testoni S., De Benedictis G.M., Negro A., Caporale G., Mascarello F., Iacopetti I., Patruno M.. Effects of in vivo applications of peripheral blood-derived mesenchymal stromal cells (PB-MSCs) and platlet-rich plasma (PRP) on experimentally injured deep digital flexor tendons of sheep.. J. Orthop. Res. 2013;31:306–314.
    doi: 10.1002/jor.22205pubmed: 22893604google scholar: lookup
  26. Dakin S.G., Werling D., Hibbert A., Abayasekara D.R., Young N.J., Smith R.K., Dudhia J.. Macrophage Sub-Populations and the Lipoxin A(4) Receptor Implicate Active Inflammation during Equine Tendon Repair.. PLoS ONE 2012;7:e32333.
    doi: 10.1371/journal.pone.0032333pmc: PMC3284560pubmed: 22384219google scholar: lookup
  27. Hosaka Y., Kirisawa R., Yamamoto E., Ueda H., Iwai H., Takehana K.. Localization of cytokines in tendinocytes of the superficial digital flexor tendon in the horse.. J. Vet. Med. Sci. 2002;64:945–947.
    doi: 10.1292/jvms.64.945pubmed: 12419874google scholar: lookup
  28. Hosaka Y., Teraoka H., Yamamoto E., Ueda H., Takehana K.. Mechanism of cell death in inflamed superficial digital flexor tendon in the horse.. J. Comp. Pathol. 2005;132:51–58.
    doi: 10.1016/j.jcpa.2004.06.006pubmed: 15629479google scholar: lookup
  29. Al-Sadi O., Schulze-Tanzil G., Kohl B., Lohan A., Lemke M., Ertel W., John T.. Tenocytes, pro-inflammatory cytokines and leukocytes: A relationship?. Muscles Ligaments Tendons J. 2011;1:68–76.
    pmc: PMC3666474pubmed: 23738251
  30. Schulze-Tanzil G., Al-Sadi O., Wiegand E., Ertel W., Busch C., Kohl B., Pufe T.. The role of pro-inflammatory and immunoregulatory cytokines in tendon healing and rupture: New insights.. Scand. J. Med. Sci. Sports. 2011;21:337–351.
    doi: 10.1111/j.1600-0838.2010.01265.xpubmed: 21210861google scholar: lookup
  31. Burk J., Paebst F., Brehm W., Piehler D., Schubert S., Tarnok A., Hillmann A.. Context-sensitive immunomodulation by equine multipotent mesenchymal stromal cells in a novel co-culture assay; Proceedings of the DVG Expert Group Physiology and Biochemistry; Vienna, Austria.. 21–23 February 2018; p. V08.
  32. Cassano J.M., Schnabel L.V., Goodale M.B., Fortier L.A.. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.. Stem Cell Res. Ther. 2018;9:82.
    doi: 10.1186/s13287-018-0840-2pmc: PMC5883371pubmed: 29615127google scholar: lookup
  33. Taylor S.E., Vaughan-Thomas A., Clements D.N., Pinchbeck G., Macrory L.C., Smith R.K., Clegg P.D.. Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems.. BMC Musculoskelet. Disord. 2009;10:27.
    doi: 10.1186/1471-2474-10-27pmc: PMC2651848pubmed: 19245707google scholar: lookup
  34. Abate M., Silbernagel K.G., Siljeholm C., Di Iorio A., De Amicis D., Salini V., Werner S., Paganelli R.. Pathogenesis of tendinopathies: Inflammation or degeneration?. Arthritis Res. Ther. 2009;11:235.
    doi: 10.1186/ar2723pmc: PMC2714139pubmed: 19591655google scholar: lookup
  35. Parkinson J., Samiric T., Ilic M.Z., Cook J., Handley C.J.. Involvement of proteoglycans in tendinopathy.. J. Musculoskelet. Neuronal. Interact. 2011;11:86–93.
    pubmed: 21625045
  36. Roth S.P., Schubert S., Scheibe P., Gross C., Brehm W., Burk J.. Growth factor-mediated tenogenic induction of multipotent Growth factor-mediated tenogenic induction of multipotent mesenchymal stromal cells is altered by the microenvironment of tendon matrix.. Cell Transplant. 2018 submitted.
    pmc: PMC6180728pubmed: 30251565
  37. Vallés G., Bensiamar F., Crespo L., Arruebo M., Vilaboa N., Saldaña L.. Topographical cues regulate the crosstalk between MSCs and macrophages.. Biomaterials 2015;37:124–133.
    doi: 10.1016/j.biomaterials.2014.10.028pmc: PMC4245715pubmed: 25453943google scholar: lookup
  38. Proctor W.R., Foster A.J., Vogt J., Summers C., Middleton B., Pilling M.A., Shienson D., Kijanska M., Ströbel S., Kelm J.M.. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury.. Arch. Toxicol. 2017;91:2849–2863.
    doi: 10.1007/s00204-017-2002-1pmc: PMC5515971pubmed: 28612260google scholar: lookup
  39. Pourgholaminejad A., Aghdami N., Baharvand H., Moazzeni S.M.. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.. Cytokine 2016;85:51–60.
    doi: 10.1016/j.cyto.2016.06.003pubmed: 27288632google scholar: lookup
  40. Lu Z.-Y., Chen W.-C., Li Y.-H., Li L., Zhang H., Pang Y., Xiao Z.-F., Xiao H.-W., Xiao Y.. TNF-α enhances vascular cell adhesion molecule-1 expression in human bone marrow mesenchymal stem cells via the NF-κB, ERK and JNK signaling pathways.. Mol. Med. Rep. 2016;14:643–648.
    doi: 10.3892/mmr.2016.5314pmc: PMC4918617pubmed: 27221006google scholar: lookup
  41. Jin P., Zhao Y., Liu H., Chen J., Ren J., Jin J., Bedognetti D., Liu S., Wang E., Marincola F.. Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype.. Sci. Rep. 2016;6:26345.
    doi: 10.1038/srep26345pmc: PMC4876328pubmed: 27211104google scholar: lookup
  42. Zhang K., Asai S., Yu B., Enomoto-Iwamoto M.. IL-1beta irreversibly inhibits tenogenic differentiation and alters metabolism in injured tendon-derived progenitor cells in vitro.. Biochem. Biophys. Res. Commun. 2015;463:667–672.
    doi: 10.1016/j.bbrc.2015.05.122pmc: PMC4496264pubmed: 26051275google scholar: lookup
  43. Gaida J.E., Alfredson H., Forsgren S., Cook J.L.. A pilot study on biomarkers for tendinopathy: Lower levels of serum TNF-α and other cytokines in females but not males with Achilles tendinopathy.. BMC Sports Sci. Med. Rehabil. 2016;8:5.
    doi: 10.1186/s13102-016-0026-0pmc: PMC4768326pubmed: 26925234google scholar: lookup
  44. Ackermann P.W., Domeij-Arverud E., Leclerc P., Amoudrouz P., Nader G.A.. Anti-inflammatory cytokine profile in early human tendon repair.. Knee Surg. Sports Traumatol. Arthrosc. 2013;21:1801–1806.
    doi: 10.1007/s00167-012-2197-xpubmed: 22983752google scholar: lookup
  45. Han P., Cui Q., Yang S., Wang H., Gao P., Li Z.. Tumor necrosis factor-α and transforming growth factor-β1 facilitate differentiation and proliferation of tendon-derived stem cells in vitro.. Biotechnol. Lett. 2017;39:711–719.
    doi: 10.1007/s10529-017-2296-3pubmed: 28155178google scholar: lookup
  46. Chen S., Deng G., Li K., Zheng H., Wang G., Yu B., Zhang K.. Interleukin-6 Promotes Proliferation but Inhibits Tenogenic Differentiation via the Janus Kinase/Signal Transducers and Activators of Transcription 3 (JAK/STAT3) Pathway in Tendon-Derived Stem Cells.. Med. Sci. Monit. 2018;24:1567–1573.
    doi: 10.12659/MSM.908802pmc: PMC5868364pubmed: 29547593google scholar: lookup
  47. Zhang J., Li Z.-G., Si Y.-M., Chen B., Meng J.. The difference on the osteogenic differentiation between periodontal ligament stem cells and bone marrow mesenchymal stem cells under inflammatory microenviroments.. Differentiation 2014;88:97–105.
    doi: 10.1016/j.diff.2014.10.001pubmed: 25498523google scholar: lookup
  48. Ahrberg A.B., Horstmeier C., Berner D., Brehm W., Gittel C., Hillmann A., Josten C., Rossi G., Schubert S., Winter K.. Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model.. BMC Musculoskelet. Disord. 2018;19:230.
    doi: 10.1186/s12891-018-2163-ypmc: PMC6052633pubmed: 30021608google scholar: lookup
  49. Roth S.P., Erbe I., Burk J.. Decellularization of Large Tendon Specimens: Combination of Manually Performed Freeze-Thaw Cycles and Detergent Treatment.. Methods Mol. Biol. 2017.
    doi: 10.1007/7651_2017_49pubmed: 28702884google scholar: lookup
  50. Burk J., Erbe I., Berner D., Kacza J., Kasper C., Pfeiffer B., Winter K., Brehm W.. Freeze-thaw cycles enhance decellularization of large tendons.. Tissue Eng. Part C Methods 2014;20:276–284.
    doi: 10.1089/ten.tec.2012.0760pmc: PMC3968887pubmed: 23879725google scholar: lookup
  51. Scheibe P.. Fast Color Deconvolution for Histological Images with Mathematica.. [(accessed on 31 July 2018)].
  52. . Color Deconvolution ImageJ Plugin.. [(accessed on 31 July 2018)].
  53. Ruifrok A.C., Johnston D.A.. Quantification of histochemical staining by color deconvolution.. Anal. Quant. Cytol. Histol. 2001;23:291–299.
    pubmed: 11531144
  54. Bigras G.. Color deconvolution. Optimizing handling of 3D unitary optical density vectors with polar coordinates.. Anal. Quant. Cytol. Histol. 2012;34:149–160.
    pubmed: 23016461
  55. Otsu N.. A Threshold Selection Method from Gray-Level Histograms.. IEEE Trans. Syst. Man Cybern. 1979;9:62–66.
    doi: 10.1109/TSMC.1979.4310076google scholar: lookup
  56. Pfaffl M.W.. A new mathematical model for relative quantification in real-time RT-PCR.. Nucleic Acids Res. 2001;29:e45.
    doi: 10.1093/nar/29.9.e45pmc: PMC55695pubmed: 11328886google scholar: lookup

Citations

This article has been cited 28 times.
  1. Wang H, Xu A, Hua W, Mao J, Zhang J, Ma X, Lu L. Stem cell-based strategies for intervertebral disc regeneration in degenerative microenvironments: challenges and solutions. Front Cell Dev Biol 2025;13:1719332.
    doi: 10.3389/fcell.2025.1719332pubmed: 41450738google scholar: lookup
  2. Najeb M, Samy A, Rizk A, Mosbah E, Karrouf G. Regenerative biologics modulating inflammation and promoting tenogenesis in equine superficial digital flexor tendonitis: from molecular pathways to clinical translation. Ir Vet J 2025 Sep 17;78(1):21.
    doi: 10.1186/s13620-025-00309-zpubmed: 40963139google scholar: lookup
  3. Schmitz C, Alt C, Wuerfel T, Milz S, Dinzey J, Hill A, Sikes KJ, Burton LH, Easley J, Stewart HL, Puttlitz CM, Gadomski BC, Labus KM, Pearce DA, Maffulli N, Alt EU. Regeneration of Biomechanically Functional Tendon Tissue Following Injection of Uncultured, Autologous, Adipose-Derived Regenerative Cells into Partial Achilles Tendon Defects in Rabbits. Int J Mol Sci 2025 Jul 16;26(14).
    doi: 10.3390/ijms26146800pubmed: 40725049google scholar: lookup
  4. Jiang Y, Zhang Z, Ren K, Zhou S, Qiao Y, Huang W, Zhang N, Xu H, Xu X, Wen B, Zhang W, Yin L. Harnessing cell size to separate genetically and functionally distinct dental pulp-derived mesenchymal stromal cell subpopulations. J Biol Eng 2025 Jun 3;19(1):52.
    doi: 10.1186/s13036-025-00524-wpubmed: 40462207google scholar: lookup
  5. Lui PPY, Huang C, Zhang X. Selenium Nanoparticles Suppressed Oxidative Stress and Promoted Tenocyte Marker Expression in Tendon-Derived Stem/Progenitor Cells. Antioxidants (Basel) 2024 Dec 15;13(12).
    doi: 10.3390/antiox13121536pubmed: 39765864google scholar: lookup
  6. Chen J, Sheng R, Mo Q, Backman LJ, Lu Z, Long Q, Chen Z, Cao Z, Zhang Y, Liu C, Zheng H, Qi Y, Cao M, Rui Y, Zhang W. Controlled TPCA-1 delivery engineers a pro-tenogenic niche to initiate tendon regeneration by targeting IKKβ/NF-κB signaling. Bioact Mater 2025 Feb;44:319-338.
    doi: 10.1016/j.bioactmat.2024.10.016pubmed: 39512422google scholar: lookup
  7. Soukup R, Gerner I, Mohr T, Gueltekin S, Grillari J, Jenner F. Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. Int J Mol Sci 2023 Jun 29;24(13).
    doi: 10.3390/ijms241310857pubmed: 37446034google scholar: lookup
  8. Sheng R, Liu J, Zhang W, Luo Y, Chen Z, Chi J, Mo Q, Wang M, Sun Y, Liu C, Zhang Y, Zhu Y, Kuang B, Yan C, Liu H, Backman LJ, Chen J. Material Stiffness in Cooperation with Macrophage Paracrine Signals Determines the Tenogenic Differentiation of Mesenchymal Stem Cells. Adv Sci (Weinh) 2023 Jun;10(17):e2206814.
    doi: 10.1002/advs.202206814pubmed: 37097733google scholar: lookup
  9. Moellerberndt J, Hagen A, Niebert S, Büttner K, Burk J. Cytokines in equine platelet lysate and related blood products. Front Vet Sci 2023;10:1117829.
    doi: 10.3389/fvets.2023.1117829pubmed: 36968472google scholar: lookup
  10. Schmitz C, Alt C, Azares AR, Pearce DA, Facile TR, Furia JP, Maffulli N, Huang C, Alt EU. The Composition of Adipose-Derived Regenerative Cells Isolated from Lipoaspirate Using a Point of Care System Does Not Depend on the Subject's Individual Age, Sex, Body Mass Index and Ethnicity. Cells 2022 Dec 21;12(1).
    doi: 10.3390/cells12010030pubmed: 36611823google scholar: lookup
  11. Zhang J, Zhang W, Sun T, Wang J, Li Y, Liu J, Li Z. The Influence of Intervertebral Disc Microenvironment on the Biological Behavior of Engrafted Mesenchymal Stem Cells. Stem Cells Int 2022;2022:8671482.
    doi: 10.1155/2022/8671482pubmed: 36387746google scholar: lookup
  12. Heyman E, Meeremans M, Devriendt B, Olenic M, Chiers K, De Schauwer C. Validation of a color deconvolution method to quantify MSC tri-lineage differentiation across species. Front Vet Sci 2022;9:987045.
    doi: 10.3389/fvets.2022.987045pubmed: 36311666google scholar: lookup
  13. Bowers K, Amelse L, Bow A, Newby S, MacDonald A, Sun X, Anderson D, Dhar M. Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response. Bioengineering (Basel) 2022 Aug 22;9(8).
    doi: 10.3390/bioengineering9080407pubmed: 36004932google scholar: lookup
  14. Schulze-Tanzil GG, Delgado-Calcares M, Stange R, Wildemann B, Docheva D. Tendon healing: a concise review on cellular and molecular mechanisms with a particular focus on the Achilles tendon. Bone Joint Res 2022 Aug;11(8):561-574.
    doi: 10.1302/2046-3758.118.BJR-2021-0576.R1pubmed: 35920195google scholar: lookup
  15. Roth SP, Burk J, Brehm W, Troillet A. MSC in Tendon and Joint Disease: The Context-Sensitive Link Between Targets and Therapeutic Mechanisms. Front Bioeng Biotechnol 2022;10:855095.
    doi: 10.3389/fbioe.2022.855095pubmed: 35445006google scholar: lookup
  16. Lui PPY, Zhang X, Yao S, Sun H, Huang C. Roles of Oxidative Stress in Acute Tendon Injury and Degenerative Tendinopathy-A Target for Intervention. Int J Mol Sci 2022 Mar 25;23(7).
    doi: 10.3390/ijms23073571pubmed: 35408931google scholar: lookup
  17. Depuydt E, Broeckx SY, Chiers K, Patruno M, Da Dalt L, Duchateau L, Saunders J, Pille F, Martens A, Van Hecke L, Spaas JH. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries. Front Vet Sci 2021;8:789293.
    doi: 10.3389/fvets.2021.789293pubmed: 35281431google scholar: lookup
  18. Baumgartner W, Wolint P, Hofmann S, Nüesch C, Calcagni M, Brunelli M, Buschmann J. Impact of Electrospun Piezoelectric Core-Shell PVDFhfp/PDMS Mesh on Tenogenic and Inflammatory Gene Expression in Human Adipose-Derived Stem Cells: Comparison of Static Cultivation with Uniaxial Cyclic Tensile Stretching. Bioengineering (Basel) 2022 Jan 8;9(1).
    doi: 10.3390/bioengineering9010021pubmed: 35049730google scholar: lookup
  19. Melzer M, Schubert S, Müller SF, Geyer J, Hagen A, Niebert S, Burk J. Rho/ROCK Inhibition Promotes TGF-β3-Induced Tenogenic Differentiation in Mesenchymal Stromal Cells. Stem Cells Int 2021;2021:8284690.
    doi: 10.1155/2021/8284690pubmed: 34659420google scholar: lookup
  20. Meeremans M, Van de Walle GR, Van Vlierberghe S, De Schauwer C. The Lack of a Representative Tendinopathy Model Hampers Fundamental Mesenchymal Stem Cell Research. Front Cell Dev Biol 2021;9:651164.
    doi: 10.3389/fcell.2021.651164pubmed: 34012963google scholar: lookup
  21. Depuydt E, Broeckx SY, Van Hecke L, Chiers K, Van Brantegem L, van Schie H, Beerts C, Spaas JH, Pille F, Martens A. The Evaluation of Equine Allogeneic Tenogenic Primed Mesenchymal Stem Cells in a Surgically Induced Superficial Digital Flexor Tendon Lesion Model. Front Vet Sci 2021;8:641441.
    doi: 10.3389/fvets.2021.641441pubmed: 33748217google scholar: lookup
  22. Liu W, Luo H, Wang R, Kang Y, Liao W, Sun Y, Chen G, Shao L. Rapamycin-Induced Autophagy Promotes the Chondrogenic Differentiation of Synovium-Derived Mesenchymal Stem Cells in the Temporomandibular Joint in Response to IL-1β. Biomed Res Int 2020;2020:4035306.
    doi: 10.1155/2020/4035306pubmed: 33145347google scholar: lookup
  23. Jauković A, Kukolj T, Obradović H, Okić-Đorđević I, Mojsilović S, Bugarski D. Inflammatory niche: Mesenchymal stromal cell priming by soluble mediators. World J Stem Cells 2020 Sep 26;12(9):922-937.
    doi: 10.4252/wjsc.v12.i9.922pubmed: 33033555google scholar: lookup
  24. Janvier AJ, Canty-Laird E, Henstock JR. A universal multi-platform 3D printed bioreactor chamber for tendon tissue engineering. J Tissue Eng 2020 Jan-Dec;11:2041731420942462.
    doi: 10.1177/2041731420942462pubmed: 32944210google scholar: lookup
  25. Voga M, Adamic N, Vengust M, Majdic G. Stem Cells in Veterinary Medicine-Current State and Treatment Options. Front Vet Sci 2020;7:278.
    doi: 10.3389/fvets.2020.00278pubmed: 32656249google scholar: lookup
  26. Evrova O, Kellenberger D, Calcagni M, Vogel V, Buschmann J. Supporting Cell-Based Tendon Therapy: Effect of PDGF-BB and Ascorbic Acid on Rabbit Achilles Tenocytes in Vitro. Int J Mol Sci 2020 Jan 10;21(2).
    doi: 10.3390/ijms21020458pubmed: 31936891google scholar: lookup
  27. Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med 2019;4:22.
    doi: 10.1038/s41536-019-0083-6pubmed: 31815001google scholar: lookup
  28. Schulze-Tanzil G. Intraarticular Ligament Degeneration Is Interrelated with Cartilage and Bone Destruction in Osteoarthritis. Cells 2019 Aug 27;8(9).
    doi: 10.3390/cells8090990pubmed: 31462003google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.